Timofei Rusu
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preclinical PET characterization of [68Ga]Ga-EMP-100 for non-invasive assessment of c-Met in NSCLC.
Journal: EJNMMI research
Published: March 04, 2026
68 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas.
Journal: Clinical nuclear medicine
Published: January 30, 2025
Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 18, 2023
Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut.
Journal: Medicine
Published: December 01, 2022
Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Different Contexts: A Retrospective Study.
Journal: Clinical nuclear medicine
Published: March 21, 2022
Restaging the Biochemical Recurrence of Prostate Cancer with [68Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management.
Journal: Cancers
Published: February 20, 2021
Ultra-fast liquid chromatography method coupled with ultraviolet detection to quantify dimethylsulfoxide, dimethylformamide and dimethylacetamide in short half-lives radiopharmaceuticals.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: January 29, 2021
Comparison of 51Cr-EDTA and 99mTc-DTPA for glomerular filtration rate measurement.
Journal: Journal of nephrology
Published: August 25, 2020
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models.
Journal: Nuclear medicine and biology
Published: January 01, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026